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ABSTRACT
Thrombosis is an initiating response to a vascular injury, which aids in the repair and
remodeling of the vessel wall. However, if this process remains unchecked, occlusion of
the arterial lumen may quickly occur. The arterial vascular bed is a delicate and life-
sustaining environment, in which a pathological thrombosis can bring about devastating
conclusions such as acute vascular syndromes or post-interventional thrombosis. In order
to explore these flow-dependent thrombotic reactions, it is essential to consider the
physical environment present inside the vasculature. A novel in vitro, high-throughput
method for creating one-pass blood flows has been developed to model the arterial
environment. Flow is generated in a matrix of small glass tubes with varying inner
diameters through the use of a constant pressure drop. Using this technique, a variety of
flow rates are created in the numerous tubes, resulting in a variety of flow shear rates. In
addition, this technique allows for the monitoring of sensitive, flow-dependent processes
without the disturbances from pump action and circuit effects. A detailed discussion
about the goals of the proposed systems is included, as well as the methodology
employed to choose the optimal flow system, and the process by which the components
of the system evolved in design. Finally, tests are formulated in order to explore the
issues of biological feasibility, noise, precision, and accuracy related to the proposed
system and make to make improvements on the design accordingly.
Thesis Supervisor: Elazer R. Edelman
Title: Thomas D. and Virginia Cabot Professor
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CHAPTER 1
Background and Significance
1.1 Vascular Thrombosis
1.1.1 Significance
During states of health, all parts of the vascular system are lined with an endothelial
barrier that separates and protects the highly reactive vessel wall from the blood flowing
within. This biological environment is greatly affected by several cellular mechanisms
such as gene expression patterns and surface receptor expression [1]. These mechanisms
allow for the living endothelial surface to change according to the local physiological
needs.
This protective endothelial surface is continually injured by environmental and genetic
factors. Although these injuries are of very low severity, they cause the accumulation of
subendothelial deposits of lipids and lipid-laden macrophages that initiate a complex
cycle of chronic inflammation, smooth muscle cell proliferation and migration,
extracellular matrix turnover, and the build up of cellular and necrotic debris [2-6]. The
accumulation of these materials and processes develop into atherosclerotic disease and
luminal stenosis. A healthy arterial lumen is compared against a lumen experiencing
narrowing by atherosclerosis in Figure 1.
A B
Figure 1: A) Healthy arterial lumen B) Arterial lumen narrowed by atherosclerosis.
These atherosclerotic plaques are characterized by a lipid laden, necrotic core that is
covered by a fibrous cap region. This atherosclerotic process can continue over a lifetime
and eventually lead to significant reduction in lumen area, on the level of >75%
reduction. Regulatory mechanisms of the body can account for these progressively
growing plaques by compensating with increased blood flow. Although this situation can
be somewhat accounted for naturally and safely by the body, a plaque eruption or
endothelial erosion can be unpredictable and treacherous [3-5, 7, 8]. One of these events
can expose the highly reactive subendothelial layer and accelerate the progression of
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Chapter 1: Background and Significance
disease, which can then bring about unstable angina, myocardial infarction, or ischemic
sudden death.
1.1.2 Biological Components
Although great deals of factors are involved in vascular thrombosis, this study will focus
on the blood and wall as the primary parts involved. Specifically, the element in blood
that relates most to the vascular response to injury is the platelet. A platelet is a cell that
circulates along with blood in concentrations ranging between 1.5 - 4.5 x 108 cells/mL
[91. Platelet reactions with walls are an incredibly important factor in thrombosis as is
evidenced through the successful clinical use of anti-platelet drugs in order to minimize
thrombotic risk [10]. Upon binding to a wall, these platelet-wall reactions occur in a
series of steps. They first alter their expression of surface molecules and release
substances which both attract and adhere to flowing cells, as well as promote the
enzymatically driven coagulative response.
The adherence, or tethering, of a platelet to a vascular wall is the outcome of several
biochemical processes actively occurring in the blood. The speed with which the bonds
are created in these biochemical processes is a determining factor of the effectiveness of a
platelet to tether to a surface under given flow conditions, and therefore the rate at which
platelets collect at a site. Studies have shown that these tethering activities become
increasingly important as blood shear rates increase above 300 s-, and are nearly the sole
factor in platelet tethering at rates around 1500 s-1 [11, 12]. After a platelet binds to the
wall surface, it undergoes a shape change which is accompanied by the release of
substances such as ADP and thromboxane. Platelets flowing freely in the blood can then
be activated by the released molecules, which enhance their binding affinity to the
activated receptors on the surface of the bound platelets. Platelets are necessary in the
support of coagulative propagation, a process initiated by internal or external factors, but
results with the conversion of monomeric fibrinogen to fibrin. The monomeric fibrin
quickly polymerizes into a mesh network of filaments onto which platelets can adhere.
This process strengthens the overall cohesiveness of this aggregating, hemostatic plug
which helps to protect and close the wound.
In addition to the specific characteristics of blood that contribute to coagulation, the
physiology of the arterial wall has great influence on the process of clotting. As explained
before, the process begins with the damaging of the layer of the arterial inner wall which
contacts blood. This layer is composed of endothelial cells which die when damaged.
This damage can lead to sub endothelial layer exposure. The cells and proteins of this
formerly protected layer can then react with the selectins or integrins found in blood.
Specifically, the layer can react with collagen, fibronectin, and can absorb Von
Willebrand Factor, which is present in all plasma. Also, the wall can react with tissue
factor, the initiating factor in coagulation [2-6]. Initially, the test proposed in this
document will focus on the effects of shear rates on collagen, later on tissue factor will be
tested as well.
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1.1.3 Physical Environment
Biological interactions occurring inside the vasculature are at least partly caused by the
physiological environment, especially inside the hemodynamic setting of the body's
vasculature. The flow of blood in this environment allows for the maintenance of
diversity as well as the control of vascular responses. The flow conditions in this setting
vary by both time and space, affected by the systolic and diastolic phases of a beating
heart, as well as curving vessels, numerous branch points, and geometric pathologies [14-
17]. The complex flow patters created by these features must be taken into account when
considering highly flow-sensitive events such as thrombosis.
1.1.3.1 Flow
Blood flow can affect the biological interactions occurring in a body, beginning at the
molecular and microscopic scales, and up to the macroscopic scale. Some of these
interactions include physical forces and mass transport, as well as sophisticated
machinery developed by the body to adapt to changing surroundings.
1.1.3.2 Molecular Interactions
Blood flow can affect the biological interactions occurring in a body, beginning at the
molecular and microscopic scales, and up to the macroscopic scale. Some of these
interactions include physical forces and mass transport, as well as sophisticated
machinery developed by the body to adapt to changing surroundings [18].
1.1.3.3 Microscopic Interactions
There are two important regulators of molecular interactions in the vascular environment:
cellular transport and wall reactivity. Cellular components are transported to and from
reactive surfaces by a special diffusion coefficient, specific to non-Newtonian fluids. This
coefficient is dependent on the concentration of red blood cells in flow, which happen to
migrate to the flow axis. This causes platelets to migrate to the flow periphery [13]. The
reactivity of a vessel wall also matters with respect to the expression of surface adhesion
molecules of endothelial cells [19]. These molecules are known as selectins, and they
interact with respective ligands on free stream cells under high shear conditions. These
connections are made quickly and are not strong, but initiate pathways of vascular cell
activation, resulting in integrin receptor activation, and firm, shear-resistant adhesion to
surface ligands.
1.1.3.4 Macroscopic Interactions
On the macroscopic scale, shear stresses caused by blood flows can impact the spread
and development of a vascular disease. Atherosclerotic plaques are characterized by an
atheromatous core region covered by a fibrous cap, which can cause the rupture of the
plaque if removed [20-23]. As a thrombus increases in size by the aggregation of cells
and molecules, it is subject to increasing fluid forces. These increased stresses can bring
about the rupture of the plaque, which can eventually result in a dangerous embolism.
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1.2 Methods of Studying Flow Dependent Thrombosis
A large variety of methods to study flow dependent processes and effects in the
vasculature have been developed in the past. These tests have ranged from in vivo, to ex
vivo, to in vitro technologies. New testing methods and devices have been devised to
improve upon the performance limits previous models, as well as to include new
information about the system gathered from recent studies. As a result of all these tests,
each one has its own set of advantages and disadvantages, and therefore some are more
suited to test certain variables and conditions than others. The use of all these
experimental procedures has brought us to our current knowledge about the environment,
physiological processes, and biochemical pathways that exist in the vascular setting.
1.2.1 In Vivo Strategies
In vivo methods of studying flow dependent thrombosis are used routinely in human
studies and clinical trials. During human studies, the primary goal is to apply technology
and knowledge towards the immediate improvement of the patient's condition. Animal
studies, in comparison to human studies, are more controlled and cost less to administer,
although the applicability to the human condition usually becomes a factor when results
have been obtained. These types of investigations are valuable because they take into
account complex biological interactions in the body, such as integrated, systemic, and
long-term processes [9]. Advantages can also be found in disease characterization, patient
risk stratification, and the efficacy of therapeutic options. On the other hand, because of
the objectives of these tests, as well as the lack of ideal controls and the variations
between individual patients, scientific progress during one of these endeavors is difficult.
On top of that, the tests can also be expensive, take a great deal of time to complete, and
the final conclusions may be unclear, and therefore not directly applicable to the towards
progress in the research field.
1.2.2 In Vitro Strategies
In vitro testing procedures allow for parametric control over hemodynamic and complex
biological environments. Generally during in vitro experiments of physiological flow
dependent processes, tests fall into one of two categories: control is taken over the
physical geometries, or control is taken over the flow conditions. When geometry is
maintained constant the main advantage obtained is the possibility to maintain realistic
vascular dimensions in the testing components. Several problematic issues are also
associated with these types of testing, namely finding suitable methods for flow actuation
and control. One pass and fluid loop systems have been devised to work out some
problems, but new issues have risen. One pass systems generally contain a static holding
volume for the blood to be tested, which greatly constrains available flow rates,
experimental run times, and constant flow conditions [25]. Fluid loop systems allow for
the use of small volumes of blood, but have problems associated with blood recirculation
and air-fluid interfaces [26-28]. In order to better control flow activation and control,
pumps may be implemented into a design, but it is difficult to find suitable pump whose
drive train does not activate platelets [29-30]. The activation of platelets means that this
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environment is too traumatic to appropriately represent the arterial environment in
experiments.
The use of constant geometry in experiments required the use of high flow rates to
generate arterial-like flows. Because of this, liberties have been taken with the
architectural design of flow setups, in order to create small circuit geometries. Examples
include parallel plate chambers that allow for high shear rates under low flow, high levels
of control over the environment, and the ability to visualize in real time [26, 24, 31-33].
Another example is the cone-plate or annular ring device that creates wall shears though
Cuvette-type flows [17, 34]. Through the use of non-dimensional parameters and specific
conditions, a miniature model can be related to a physiological architecture, and therefore
prove useful as a source of experimental information.
1.2.3 Rotational Systems
Among the in vitro constant flow experimental techniques a novel method to create flows
and wall shears was developed by Kumaran Kolandaivelu [35]. The method developed
involved the angular acceleration of fluid filled loops about their axis. Flow was
generated by inducing wall motion relative to the contained fluid. The flow was
predetermined and controlled in order to modulate the fluid motion in relation to the wall
through the transmitted shear forces. In addition, a variety of pulsatile flow patterns
could be developed and modulated in order to mimic the physiological hemodynamic
setting. This system had the advantages that it was able to accurately monitor sensitive
flow dependent processes, received no disturbances from a pump mechanism, and
utilized low test volumes as well as generated low costs.
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1.3 Motivation for High-Throughput Strategies / Proposed Flow System
Table 1 compares prior flow systems that have been utilized to study the hemodynamics
of thrombosis with respect to the human condition.
Table 1: Comparison of flow system attributes. (Subjective scale that ranges from +++ ---, which is
equal to Excellent Poor.)
Experimental System Performance Attributes
Systems
_ ~ ~~~~~~~~- .- .. OD~~~ 0 0~~~0
0f 'Eb ~7j Z 0. 0 0 cocQ). 0 ' ~< 00 40 0 U-- 0 . o o ~ ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~ ~~~~~~~- 
In Clinical +++ +++ +++......... NA . .
Vivo Trials
Large ++ ++ ++ .. NA -
Animal
Studies
Small + + - + . NA
Animal
Studies
In Gravity -- ++ + -+ + --- + ++ ++
Vitro Driven
Systems
Peristaltic . ++ ++ ++ + + -+ ++ ++
Systems___
Parallel -- ++ -++ ++ ++ +++ . ++ +++ ++ +++ ++ ++
Plate
Chambers
Cuvette -- ++ -++ + ++ ++ ++ + + ++ ++
S ystem s _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ _ _ _ _ _
Rotational --++ ++ ++ + ++ + ++ ++ ++ +
Systems
Ex Ex Vivo ++ ++ + + -- + -NA +
Vivo Circuits 
The combination of all these types of tests has generated a great deal of the information
we currently know about thrombosis and the intravascular setting. Some test types, such
as Ex Vivo circuits have even bridged the gap between In Vivo and In Vitro studies. Still,
problems remain with each of these tests, and therefore new methods must be developed
in order to perform new studies and gather new types of information.
Newer testing methods, especially the apparatus that creates inertial flow caused by an
accelerating loop, successfully tackled several issues related to previous testing methods.
The inertial flow method focused on gaining more control over the biological
environment, creating physiologically relevant flows, as well as maximizing the
biological signal while reducing the background noise. While the system was successful
in reaching these goals, it had several problems which were solved through the key
criterion of our new mechanism design:
1. The ability to test a large variety of conditions concurrently
2. Utilize a small sample of blood to run all the tests
3. Allow for the operator of the machine to be able to output accurate and
consistent data, while following simple instructions for use.
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After considering several routes for improvement upon the spinning loop design, a high
throughput, one-pass, pressure drop driven flow mechanism was developed. Briefly,
blood flows through 384 glass capillaries, by the help of a pressure drop, and is
experiences differing flow conditions in each tube. The construction of this one-pass
system then allows for easy assaying of the sample and monitoring of the biological
signal. This method allows for the use of small test volumes and cost, allowing for a large
amount of parametric analyses to be carried out on the sample
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CHAPTER 2
High-Throughput Strategies
The new iteration on a flow system design, described at the end of Chapter 1, strives to
serve as a high throughput blood flow testing mechanism, which operates on a relatively
small sample of blood. More specifically, several constraints and goal parameters had to
be met in order to consider this mechanism an improvement over other systems,
especially over the successful accelerating loop design. The performance characteristics
of several blood flow systems were compared in the Pugh chart found in Table 1. The
new design of the system had to improve upon several system aspects, such as: range and
number of flow conditions, minimum volume of blood per sample, time to run each phase
of the test, and the ease of setting up the apparatus for each test phase.
2.1 Goal Parameters / Basic Constraints
One of the major problems associated with the accelerating loop design was the ability to
vary the range and number of flow conditions. This system allowed for variations in flow
conditions by manipulation of the program file that sent the input signal to the motor of
the apparatus. If the correct mathematics were carried out, one could successfully output
a variety of pulsatile flows, of varying frequencies and amplitudes. Unfortunately, due to
the nature of this system, the number of flow conditions that could be tested in parallel
was a function of the number of rotors built into the system. Because of the size of the
incubator that held the apparatus, the maximum number of rotors that could be built into
the system was about two to three. Although a number of experimental condition repeats
could be mounted onto a single rotor, only about two different experimental conditions
could be tested in the time allotted for a test. The new flow system needed to
concurrently test a large number of one or more variables, and have repeats of each
condition to ensure precision. Early in the design process it was determined that
designing the tool for direct use with a 384 well plate would be an efficient way to ensure
that a great deal of conditions may be tested. Therefore, three repeats of 128 condition
variations could be potentially tested. This was already a large improvement in terms of
testing volume from the rotating loop, which at maximum could handle six repeats of two
testing conditions.
Another issue associated with the accelerating loop was the volume of blood per sample.
Each tube loop required a 3 mL blood sample to provide data. While this is initially a
feasible amount of blood to draw from a specimen, performing tests on a variety of
conditions will soon require much greater amounts of blood. This would become a
problem if the system were to ever enter into a population study where a large amount of
samples and data would be necessary to arrive at any strong conclusions. One of the goal
parameters of this new system would be to perform all 384 tests on 16 blood samples of 3
mL volume each. This system would have flow chambers of diameter smaller than
physiological size in order to create high shear rate flows at low volumetric flow rates.
Finally, it was of great importance to count in the human factor of the design of this new
device. The rotating loop apparatus had several problems associated with its ergonomics
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in conjunction with the time dependent characteristics of blood. Blood reacts with any
surface it comes into contact, therefore minimizing the amount of surface the blood
touches as well as the time in contact, is important in receiving a good biological signal
from experimentation. Each test in the rotating loop took from three to five minutes to
complete, but before running the test, each loop had to be filled with blood. The filling
process could require up to one minute per loop, and if six were to be loaded onto a rotor
before testing, the first loop would have sat five minutes longer than the last even before
testing began. Considering the time involved in all these processes, a comparison
between the signals received from each sample is flawed because of the large disparity in
the times the blood samples spent in each loop. It was therefore necessary to find a
method that would avoid blood loading issues by utilizing the fewest intermediate steps
possible when loading the blood. Also it had to allow for all the blood to be loaded at the
same time, or at least with a very small amount of time difference in storage waiting for
testing. Specific methods to achieve these goals involved saving time during the
experiment, by designing components of the apparatus that either served multiple
purposes, or could be quickly swapped between different phases of the experiment.
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2.2 Rationale for Rotational and Linear Flow Model Pursuit
Once the basic constraints and parameters of the new model were outlined, two high
throughput flow models were proposed: a rotational and a linear flow model. The
rotational model was the one most directly derived from the accelerating loop design.
This model would utilize the same basic idea as the previous iteration, which was the
application of a rotational acceleration to a fluid-filled container, in order to induce
relative movement between the fluid and container wall. In this case, though, inspiration
for the fluid containers came from a 384 well plate. The fluid containers, or wells, in this
apparatus would each be very small and hold only 7.5 tL of blood. The plate that holds
the wells would sit on a turntable which spins the plate about its center. Using
programmed spinning combinations and varying the dimensions of each well, it would be
possible to create prescribed shear rates inside the wells. This setup would be very simple
to develop as it would use very few parts, and much of the components were the same as
those utilized in the accelerating loop apparatus. The greatest obstacle in the
developmental process of this system would be determining the mathematics associated
with fluid mechanics in order to find the correct spinning parameters.
An alternative proposal to the rotational model involved a one-pass flow system. In this
system a rectangular matrix of 384 glass capillaries would serve as blood flow chambers
corresponding to each well of a 384-well plate. Each flow route would have a testing
section that is the same for all samples, as well as a resistance section in which the inner
diameter of the glass capillary varied from one sample to another. The combination of the
resistance section of the tubing with a constant pressure drop across all the tubes allowed
for each tube to test a different blood shear rate. The mathematics related to this system
were much simpler than those for the rotational model but a greater amount of time was
spent on the design of the various components to be used in the system, so that 384 blood
samples may be handled safely and efficiently.
In order to initially determine the feasibility of either one of these systems, it was
necessary to provide a theoretical model of the blood flows. In the case of the rotational
model, it was of great importance to determine measurements of the well and the angular
acceleration that must be imparted upon the plate in order to create the wall shear rates. It
was necessary to figure out whether the accelerations and rotational speeds needed for
this system could be reached by the motors and equipment provided in our lab. In
addition, the feasibility of the system also rested on secondary effects of spinning, such as
the centrifugation of cells, which would provide bad results. The one-pass flow system
also needed to pass through feasibility testing by a theoretical model. This model would
determine the amount of resistance that needed to be applied to the blood flow in order to
reach our goal shear rates. Determining the amount of resistance directly informs us
about component parameters such as the inner diameter and length of the resistance
section tubing.. These features must all be taken into consideration when designing the
parts of the machine.
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CHAPTER 3
High-Throughput Model Design
3.1 Rotational Flow Model (Model A)
3.1.1 Theory
3.1.1.1 Description of situation
The rotational flow model was a high throughput evolution of the flow model developed
by Kolandaivelu [35]. A fluid filled container was accelerated about its axis of symmetry
to create wall motion in relation to the fluid, whose angular speed lagged behind that of
the wall because of its own inertia. The relation between the wall and fluid's rotational
velocity became the wall shear rate, which is of interest to us in our flow model. With the
use of periodic accelerations and decelerations, one could ideally maintain a particular
shear rate in a fluid filled container. In this particular model, the containers that held the
fluid were the size of a well from a 96 well plate and were arranged on a circular disk that
was spun from its center. The advantage of this setup was that it potentially allowed for
the easy loading and testing of many samples of blood, as well as it would allow for an
easier assay of the samples, and would allow us to obtain a great deal of data.
3.1.1.2 Rotating bucket example
The rotating bucket is a classic name given to the situation where a closed cylindrical
fluid filled cavity is spun up from a standstill. The analysis of this type of system is much
easier when assumptions such as the fluid being in rigid body rotation or an infinitely
long cylinder, can be made. This approximation, though, cannot be applied to a finite
length situation, as experimental results will vary greatly from the theoretical results. For
a liquid of low viscosity, a relatively long time is required for the liquid to rotate as a
solid body, and even through this transitional period, the fluid flow may become unstable
[36]. The reason that an assumption that the cylinder is infinitely long cannot be made is
because it had been found that the effects of cylinder ends on the fluid motion can
actually dominate the flow, even in very slender cylinders. This fluid motion is affected
by a secondary flow caused by the cylinder ends, in a region called the Ekman layer,
which convects the fluid from the walls to the interior of the cylinder. As a result, the
fluid attains rotational velocity much more quickly than without these secondary flows.
3.1.1.3 Equations and Solutions
In the particular case of rotationally symmetric flow, with small radial and axial
secondary flow in the interior, Greenspan [37] explains that the azimuthal fluid spin-up is
governed by:
av av aFV a Va+U t +_ = v + -r ar, Eq. 1
at ar F L ar 
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where u is the radial velocity, v is the azimuthal velocity, and r is the well radius. This
can then be solved by
u ~ Eq. 2u K(QV' 2 (rQ2 v ) q2
where Q is the angular velocity and K=0.886. Greenspan explained that when K=1,
Equation 2 becomes identical to the corresponding equation for linear spin up. In
addition, he made several substitutions into the resulting equation:
r v t(vQg' / 2 a vR =-,V = rT A ,E 2
a a~ ' T h h' 2h 2
-v+(v-R ( ° =A2E2 a2V a V Eq. 3+v (V =Ra A-2 E2 
At a OR R cR 2 R R
In the previous equation, a is the radial distance from the center of the well, A is the
aspect ratio, E is the Ekman number, and the portion A-2E1/2 can be substituted with ao. In
their paper, Watkins and Hussey [38] explained that depending on the size of ao, the
equation can be solved in different manners. A small ao indicates that the system
response to the rotation of the cylinder is very much dependent on the Ekman layer. On
the other hand, if ao is large, it indicates that the response of the fluid to the acceleration
of its container is mostly to completely dependent on, viscous effects from the cylinder
wall. There is also the regime of ao that falls in between both extremes and considers a
combination of the two effects. Unfortunately, of the three regimes only the small ao has
been studied extensively, while only very rough solutions have been found for the rest. In
this model we only want to deal with viscous effects, in order to avoid secondary flows in
the well. In the case that ao is large, its solution is found in the form:
-1 JI~j,,R) -j 2 Vt
=R+2 Z[ Ji(I R)]e p X a2 Eq. 4
n=l J (J )] (, a ) '
where Ji is the Bessel function of the first kind of order I andjn is the nth zero of Jo. This
equation was solved with the use of the program Excel for a variety of conditions. The
extreme conditions, especially the maximum shear rates that we wanted to test, were
focused on in order to determine the feasibility of this type of apparatus. While
determining the parameters necessary to create the maximum shear rates, it was
necessary to take note of the well radius, the maximum rotational speed reached by the
spinning platform, ao, the centrifugal acceleration experienced by the fluid in the well,
the volume of blood in the well, and the time for the fluid to reach a state of solid body
rotation. The results of experimenting with the upper limit conditions revealed the results
presented in Table 2.
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Table 2: Results of solving Equation 4 for extreme arameters.
Shear Rate Rweu [cm] Tsolid body Max RPM ao Centrifugal Blood
[s ' 1] rotation Acceleration Volume
(@ r=lcm) [G] [mL]
3980.47 0.5 0.15 9300.00 0.012 968.69 0.98
4007.53 2 10.0 3780.00 0.001 160.03 15.0
The information in the table simply deals with the conditions necessary to produce the
upper limit shear rate which was 4000s-I; as confirming whether the apparatus is capable
of these limits determines the feasibility of the device. The largest difference between the
two cases presented in the table is found in the radius of the well (Rwell), where one well
is about the size of a well in a 96 well plate, while the other is much larger to provide a
good contrast. The advantages of a small well can be seen in this table. The small well
requires a much smaller blood volume, allowing for nearly 60 experiments to be run from
a normal sized blood sample, which is generally about 60mL. The larger volume would
only allow around 4 tests to be taken. Also, the smaller well requires much less time for
the fluid in the well to achieve a state of solid body rotation, because of viscous effects
and its greater surface area to volume ratio. This figure is important when considering
that the cylinder would have to cycle through acceleration and deceleration phases in
order to continually create the shear rates required by the test. A Tsolid body rotation of 0.15s is
much easier to work with than one of 10.0s, which would take up a great amount of time
considering that each test would only run between 1-2 minutes. Advantages to using a
larger well volume include the need to accelerate the cylinder to a considerably lower
final rotation rate to achieve comparable shear rates, and therefore lower centrifugal
accelerations are also expected. In theory, this system should reach its maximum
rotational speed in less than 0.1 s.
Outside of the advantages of one well size over another, the table provides information
that indicates this testing method would not be feasible. In order to meet the goal shear
rates of around 4000 s-1, high rotation rates must be reached by the motors running the
experiment. These rotation rates will then cause great centrifugal accelerations in each
well, which quickly approach blood separation values as one increases the distance
between the center of the plate and the well. As a rule of thumb, blood centrifuged at
rates between 300-500 G's begins to separate between plasma and cells after only a few
minutes. The generation of this effect would be very detrimental to the results of this
experiment. In addition, the value of ao becomes very small at these rotational rates,
which indicates that this system should actually be solved using the small ao
approximations of Equation 3. Moreover, the fact that this system has a small ao denotes
that the rotation of the fluid is very dependent on the Ekman layer, which in turn means
that the fluid rotation is greatly influenced by secondary flows present. These secondary
flows would be very detrimental in the simulation of the simplified physiological
environment that this model is aiming to create, and needs to be avoided as much as
possible.
Finally, during the research that was completed for this model, it was found that "spin
down" or the deceleration of the fluid inside a sealed cylinder, was not symmetric to
"spin up," or the acceleration of the fluid [39]. Spin down can occur in an impulsive or
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finite manner. During an impulsive spin down the fluid particles near the cylindrical wall
will rapidly experience a centrifugal instability. This centrifugal instability can lead to the
creation of "Taylor Gortler" vortices along the side wall [40]. As spin down proceeds, the
smaller vortices coalesce into larger ones, generating a much more rapid spin down that
what would be predicted by nonlinear theoretical arguments. This problem can be
delayed by conducting spin down over a finite period of time. The problem may even be
completely avoided in the slowest deceleration conditions, but the problem with this
solution is clear in this test. The time needed to decelerate, and/or change the rotation
direction of the fluid is of great importance, and a great deal of time cannot be applied
towards deceleration of the fluid.
The combination of all of these technical difficulties led to the decision to explore the
feasibility of a high throughput, one-pass linear flow device design.
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3.2 Linear Flow Model (Model B)
3.2.1 Theory
3.2.1.1 Description of Situation
In order to create the desired flow profiles, and therefore, the desired wall shear rates, a
fluid flow was generated down the length of the flow tube by a pressure drop. The
difference between the pressures at the entrance and exit of the tube allowed for fluid to
be moved from its initial container to a final collection reservoir. The wall shear rate in
the tube was determined by the profile of the flow, which in turn was a factor of the tube
dimensions as well as the fluid flow rate. Given a particular pressure drop and volumetric
flow rate, the flow's velocity was controlled by changing the cross-sectional area inside a
tube. In the case of flow-dependent thrombotic reactions, the maintenance of velocity
gradients or shear rates was the important flow factor.
Using this technique, we hope to initially create time-invariant flows, whose flow
characteristics such as the dimensionless flow parameter Reynolds (Re) and wall-fluid
shear rate were typical of physiological blood flows found in arteries. The theoretical
model developed for this apparatus represents a straight pipe composed of three sections,
as shown in Figure 2.
Contraction[~ 1
I 
Testing Section Resistance Section
Figure 2: Cross-sectional sketch of the theoretical straight pipe model.
The three sections of the pipe are the test length, the contraction, and the resistance
length. The test length section of the model will have constant parameters across all
testing conditions. The contraction and resistance sections will vary with the shear rate
conditions.
3.2.1.1 Equations
The most important parameter of the fluid flow in this model was the shear rate
experienced between the fluid and the wall. This information could be found by solving
only the axial (z) component of velocity of the cylindrical form of the Navier-Stokes
equations (Equation 5)
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av- av VO av, a aP Ia( av 1 a2v a2v]
at r rao a ar) r2 +--Pt a +v'a Z -  + V a9 )=- a + - r  - Eq. 5
where Vz, Vr, and Vo are the velocity components in the axial (z), radial (r), and tangential
(0) directions, respectively. Also, t is time, p is the fluid density, and 5P/.5z is the axial
pressure gradient. In the case of our specific model with its circumferential and axial
symmetry, Equation 5 was simplified through the elimination of several dependencies.
This was then be integrated to give
V - 1 (dPr 2 + A, r+ A2 Eq.6
2-+z- E q
Equation 6 provided the velocity profile of the flow. Inputting the boundary conditions of
this system (at r = Rtube, Vz = 0, and at r = 0, dVz/dr = 0) gave us
V 2= I dP r2 1 dP R2 Eq. 7
2fl dz) 2fu dz)
Taking the derivative of this function with respect to radial distance yielded a function for
the shear rate of the flow.
av 1 (dPA
z =I r Eq.8
ar ,u dz
Finally, inputting a radial distance of half the tube diameter into this formula gave us the
fluid's shear rate against the wall.
a Vz = dP R Eq.9
Or a.-dz
In order to determine the flow profile and the wall shear rate, it was necessary to find out
the pressure head loss across a certain piping distance (major head loss), which was
found with the use of the Darcy-Weisbach equation:
A =64 L pv 2 E.1Re- (D)( 2 )Eq. 10
ReD 2
Equation 10 was used to determine the head loss across the testing and resistance lengths
of the tubing. The head loss associated with the tube contraction could then be found with
AP =-pV21 , Eq. 11.
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where V is the linear velocity of the fluid, and D1 and D2 are the diameters of the tubing
before and after the contraction, respectively.
Finally, the total head loss was equated to the sum of the losses incurred by each of the
tubing sections. The length or diameter measurements of each resistance section were
then modified until the head loss equaled the difference between the input and exit
pressures of the tube. The difference between the input and exit pressures of the tube
were set by using Equation 10 to determine the pressure drop necessary to move blood
through a simplified model of the tubing at a shear rate of 4000 s 1 (the maximum shear
rate to be tested). The parameters for the tubing included a diameter equal to that of the
test section and a total length equal to the test and resistance sections combined.
3.2.1.1 Solutions
Using the linear straight tube approximation to move blood at a shear rate of 4000 s- it
was found that the necessary pressure drop was equal to 56535 Pa. Using this figure, it
was then possible to determine the dimensions of the tube sections. All the calculations
involved the same dimensions for the test section of the tubing, which was chosen for the
reason that we could meet our targeted volumetric flow rate goals while using enough
blood for a good assay signal, which was 7.5 FL. Only the dimensions of the resistance
section changed according to the different shear rates. The dimensions of the test section
are found in Table 3.
Table 3: Dimensions of the test section of the tubing.
Attribute Measurement
Length 10.00 cm
Internal Diameter 0.03 cm
Cross-sectional Area 7.06 x 104 cm2
For the dimensions of the resistance section tubing, a choice had to be made about
whether the lengths or the diameters of the sections should be varied. Variation of length
was first investigated, but it was quickly found that the length of the longest tube would
be over 80 times the length of the shortest tube which would bring about problems with
the actual manufacture and design of the apparatus. Variation of the tube's inner diameter
would require variation between 90 microns and 300 microns, which are well within the
capabilities of modem glass capillary tube manufacturing. The dimensions of the
resistance section tubing are found in Table 4.
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Table 4: Dimensions of the resistance section of the tubing
Rated Shear 50 100 200 500 1000 2000 4000
Rate [s'1]
Length [cm] 15 15 15 15 15 15 15
Internal 0.009 0.0105 0.0125 0.0160 0.0192 0.0235 0.0300
Diameter [cm]
Cross- 6.4 x 8.7 x 1.23 x 2.01 x 2.9 x 4.34 x 7.06 x
sectional Area 10-5 10-5 10 -4 10 -4 10 -4 10 -4 10 -4
[cm2]
In addition, it was found that the head loss due to the tubing contraction (minor head loss)
was very small in comparison to the major head loss, so that the manner in which the
tubing contracts (gradual vs. sudden) matters little in this case. With the application of a
specific pressure drop, we could then control the volumetric flow rate, and therefore, the
wall shear rate in the tubing.
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3.3 Overview of Testing Protocol Using Linear Flow Strategy
Once the basic method to create blood flows and shear rates was determined, it was
necessary to continue designing according to the original high throughput demands of the
new design. The high throughput requirement of this system extended further than just
the core method used to create the shear rates. The entire system needed to be easy to use
to minimize human effort and human error in the results. Therefore, the testing protocol
had to be reviewed and revised several times in order to change the ergonomics of each
component in the system. The protocol followed during each test was composed of four
main steps: setup, the test run, passing of buffer through the system, and assaying the
results. The following is an overview of the protocol to be followed during testing with
the final apparatus. A description of all the apparatus components is provided in Section
3.4.
3.3.1 Setup
Prior to assembly of the testing mechanism, several of the components must be prepared.
All the components, including the vacuum connection, resistance block, testing blocks,
blood loading mechanism, and other blood containers, must be sterilized by autoclave.
Also, before testing, the test and resistance tubes must be coated with their respective
solutions. The resistance tubing must be coated with 1% albumin solution, while the test
tubing can be coated with collagen, Von Willebrand Factor (vWF), tissue factor (tF), or
other proteins of interest. The test tubing must be soaked in a solution of either water or
phosphated buffered saline with about 2. lmg of the coating as solute, per lmL of solvent,
for about two hours. Once the components have been prepared, they can be assembled
together. First, four rods are screwed into the holes at the corners of the vacuum
connection. The resistance section can then be slid onto the rods and mated against the lip
of the vacuum connection. Once this connection has been made, the additional rods for
the individual test blocks can be inserted and screwed in. The test blocks can be slid into
place one at a time once the three rods that correspond to it have been installed. The test
block must be inserted slowly to ensure the safe mating of the male and female ends of
the capillary tubes in the test and resistance blocks, respectfully. Each of the 16 test
blocks is fed by its individual blood supply, which allows for the testing of blood from
different persons or blood with different treatments, concurrently. If fewer than 16 blood
supplies were to be tested, then a blank test block could be installed in the place of a
regular test block. The blank test block would close off those vacuum routes, and nothing
would flow through those resistance tubes.
Once all 16 of the test block spots have been filled a bent connecting rod is passed
through both rows of blocks, and secured with a pair of washers and nuts. This feature
helps to keep all the test blocks together for easier handling. The blood loading
mechanism is placed below the test blocks, and mated to the stepped ends of the blocks.
The stacked components are then placed on top of a raised platform that allows for tube
access to the underside of the blood loading mechanism. The containers that hold the
3mL blood supply for each test block, called Vacutainers©, are then connected to their
respective nozzles on the underside of the blood loading mechanism. Next, vacuum hoses
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are connected to the two exits on the vacuum connection piece. The primary vacuum
connection, which lies at the top of the apparatus, is monitored and regulated to ensure
that a consistent pressure difference of about 56535 Pa exists throughout the entire test.
Finally, the secondary vacuum exits, on the sides of the test blocks, are connected to
another vacuum source.
3.3.2 Test Run
Once all the blood container and vacuum connections have been made, the testing of the
system can begin. The tubing system must first be primed with Hanks buffer (KCl
400mg/L, KH 2PO4 60 mg/L, NaHCO 3 350 mg/L, NaCl 8000mg/L, NA2HPO4
47.88mg/L). The vacuum suction can now be applied to the system, allowing blood to
flow upward towards the vacuum connection piece, and out the side waste exit. The
blood is allowed for flow for a period of 1 minute, or 60mL for all 384 tubes, at the
prescribed pressure drop of about 56535 Pa. After this time is up the vacuum connection
is removed and the system is allowed to come to rest at atmospheric pressure.
3.3.3 Buffer
After the system has achieved stable atmospheric pressure, the vacuum connection and
resistance block pieces are lifted and removed from the system carefully. All of the rods
are removed along with the vacuum connection and resistance block. The buffer hopper
piece is installed on top of the test block pieces and Tyrodes buffer solution (MgCI
0.75mM, CaC'12 lmM, KCl 2.7mM, NaCl 137mM, Glucose 5mM, NaHCO3 12mM, and
HEPES 10mM) is poured into it. The secondary vacuum connections can now be opened,
and the buffer is run in the reverse direction of the blood flow for 1-2 minutes at a shear
rate of 1000 sl . After the buffer has been run through the tubing, the secondary vacuum
connection is closed and the system is brought back to atmospheric pressure. Finally, the
linked test blocks are removed from the blood loading mechanism and the buffer hopper,
to enter the assay phase of the test.
3.3.4 Assaying of Results
Prior to performing the assay, a 384 well plate must be prepared. A quantity greater than
7.5 tL of 1% Triton-X solution is placed into each of the 384 wells, since each test tube
can contain exactly 7.5pL of fluid. Once the plate has been readied, the 384 well plate is
mated to the bottom side of the 384 well plate connection piece, and a spacer is placed
under the plate in order to fill in the gap below it. The connected testing blocks can then
be mated to the other side of the well plate connecting piece, and the vacuum connection
piece is then placed on top of the test blocks, allowing the lip to surround the blocks.
Next, the vacuum suction can be applied to the system, and under hand control allow for
the Triton-X in the wells to enter and fill all of the test tubes. The solution is suspended in
place for about 30 minutes, after which the solution is expelled into a new 384 well plate.
Cytotox 96( Cytotoxicity Assay (Promega) is used to measure the amount of LDH in the
fluid that was expelled into the 384 well plate from the test tubes. LDH, or Lactate
Dehydrogenase, is a chemical constitutively present in all cells. Therefore, the measure of
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the amount of LDH in a solution gives a good indication to the amount of cells that were
present when the solution was being created. Next, an amount cytotoxicity assay equal to
the amount of Triton-X used in each test tube, is pipetted into each of the 384 wells of the
plate. In this case, 7.5 tL of this assay would be placed in each well. This solution is
allowed to rest for a period of one hour, after which a stop solution composed of diluted
acetic acid is introduced into the mixture in an amount equal to the amount of
cytotoxicity assay used in each well (7.5[tL). Finally, after the hour, the plate is placed in
a plate-reading spectrophotometer, set to read at 490 nm wavelength. The instrument
indicates how much chromagen is present in each well by determining how much of the
490 nm wavelength light is absorbed by the chromagen in the solution, which has peak
absorbance at 490 nm. The outputted data from the instrument ranges numbers from 0 to
4, in proportion to the amount of 490 nm light absorbed by the solution, where 0 and 4
indicate that either none or all of the light has been absorbed, respectively.
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3.4 Model Embodiment
The linear flow model was composed of six main components, namely the test blocks,
resistance block, blood loading mechanism, vacuum connection, buffer hopper, and a
connection to the 384 well plate. Each of these components went through individual
evolutions, although the larger picture of the whole system had to be kept in mind the
whole time. The main goals of the design of each part was to determine a combination of
ease of use during operation and sanitizing, protection of fragile components, and
accuracy that allowed for one to collect a great deal of data from properly run
experiments. The design evolution of each of the six components is presented in the
following sections, briefly describing the stages of the evolution.
3.4.1 Test Block
A schematic of a basic test block is shown in Figure 3 and three-dimensional drawing of
the test block is shown in Figure 4. The test block was a specifically shaped block of
silicone rubber cast around an 8 x 3 matrix of glass tube capillaries manufactured by
Vitrocom. Each one of these capillaries had an outer diameter (OD) of lmm and an inner
diameter (ID) of 400lim. The length of each tube was also kept standard at 10cm. Each
tube was spaced in the square tubing matrix according to the spacing between wells
found in a 384 well plate. Therefore, there was a space of 4.5mm between two tube
centers along either of the axes on the plate's plane. At one end of the test block, the
tubes extended past the face of the block in order to serve as a male end of the tubing to
mate with the female end of the resistance tubing. The test block was designed to test
eight different shear rate conditions, with three repetitions of each condition. In addition,
the complete system will allow for the maximum use of 16 of these test blocks, which
equaled to a total of 384 separate test runs. A lmm step had been cast into the bottom
face of the block in order to align the block into its respective position in the blood
loading mechanism, which will be explained later.
As the rest of the testing process was thought out, the question about how buffer would
be run through the testing section was brought up. The buffer would flow in the direction
opposite to how the blood flowed and therefore a vacuum connection at the blood loading
side of the test block was necessary. The bottom face of the test block, which faces down
when the block sits on the blood loading mechanism has vacuum exit tubes built into it.
These exit holes are connected to tubing which, in turn, exit out the narrow side of the
testing block, and eventually to a vacuum source.
The first physical model of the test block is shown in Figure 5.
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Figure 3: Schematic of the test block with dimensions included in mm. (B=4.00mm, C=2.00mm,
D=1.00mm, E=2.00mm, F=2.50mm)
Figure 4: Three-dimensional drawing of the test block.
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Figure 5: Photographs of the side of the test block (left) and the top of the test block (right).
After creating the first physical model of the test block, several considerations were
added to the block's design. First, it was found that the use of a transparent silicone
would prove useful to simply view whether liquid was entering a particular tube, as well
as inform the user about any defects or damages to the glass capillaries. The next
observation that was made concerned the elasticity of the silicone material. The original
silicone was found to be very elastic, and although that is good for the protection of the
glass tubes, this characteristic can also be detrimental to the proper and accurate
alignment of the male and female ends of the tubing. A material with different
mechanical characteristics or a method of stiffening the structure would be necessary for
the final design. Third, it was found that performing any operations around the protruding
male ends of the tubing was potentially dangerous in that they could easily be broken.
Therefore, any part in contact with this face of the block needed to have plenty of
accuracy and clearance to account for these protrusions, to allow for any procedures
involving this area to ensue without hitch. Finally, it was observed that as a product of the
sheer number of connections between the testing and resistance blocks, it may be difficult
to separate the connected blocks without possibly harming the tubes.
The first two issues were dealt with together by finding a suitable silicone rubber to use
for the final application. The rubber needed to meet the particular demands of a long
enough working time to pour into the mold, transparency in order to be able to see the
tubing, and a stiff enough constitution to provide proper protection for the glass while
allowing for relatively accurate positions of the glass tubing. The material also had to be
suitable for biological experiments where it would come into contact with blood, and had
to be able to withstand several autoclave cycles. After mixing and testing the properties
of different brands and types of silicone rubbers, we found that the Silastic MDX4-4210
was the best choice.
The third issue, which concerns the accuracy involved in lining up the components
correctly in order to protect the fragile tube ends, also helped to solve the problem of the
elasticity of the rubber. The design of the test block was adapted to allow for the passage
of three guiding tubes along its length. These guiding tubes allow one to pass stiff metal
rods through the body of the test block and then through the resistance block in order to
more easily guide the male ends of the tubes in the test block into the female ends of the
tubing in the resistance section. The extra stiffness imparted onto the test block structure
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by the guiding tubes counteracted the excessive elasticity of the material. In addition, the
organization of the three guiding tubes in each test block allowed for the intuitive
orientation of the testing blocks when mating with the resistance block because of the fact
that the blocks could only fit in one manner.
The final potential problem found through the physical model dealt with the ease of
removing various test blocks from the large resistance block. In order to make this
process easier, it was believed that if the various test blocks could be connected in some
way to handle it as a single large block, this process would be much easier. Therefore, the
design was once again modified to include the passage of two small holes that traverse
the width of the block. When all the blocks were lined up, threaded rods could be passed
through these holes in order to hold together the 16 blocks as a single unit.
3.4.2 Resistance Block
The resistance block was originally designed as a 13cm long block with the same
footprint as the test block. Specifically, the dimensions of this design called for a 36mm x
13.5mm x 130mm block. This block sat upon the test block and provides the necessary
amount of resistance to the blood flow through each tube in order to control the wall
shear rate of the fluid. The original design for the resistance block called for 16 blocks to
be arranged in an 8 x 2 manner in the apparatus, in order to line up with the wells of the
384 well plate. The glass tubes were again aligned in an 8 x 3 square matrix manner, with
4.5mm between the centers of each tube along both the length and width dimensions. The
glass tubes used in the resistance block were of 3mm OD and an ID that varied between
0.09mm and 3mm, according to the results of the calculations from Section 3.2.1.1. A
schematic of the resistance block is shown in Figure 6 and three-dimensional drawings
are shown in Figure 7.
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Figure 6: Schematic of the resistance block. With dimensions included in mm. (A=4.00mm,
B=2.00mm, C=10.00mm)
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Figure 7: Three-dimensional picture of the resistance block.
In the case of the glass tubes used for the resistance block, it was initially decided that a
wide entrance on the female end of the resistance tubing would be very helpful when
trying to mate it with the male end of the test tubing. The female end of the resistance
tubing was then designed to have a lead in which we would bore out in a shop. The
female ends of the tubing would then sit flush against the surface of the resistance block
that mates with the test block. The opposite face of the resistance block was designed to
mate with a vacuum connection that would also allow for the exit of blood from the glass
tubing. In order for blood to flow out of the tubing and out of the system without adding
any resistance to the flow of blood behind it, it was determined that the tubing ends
passing through this block face had to extend 2cm. This allowed the blood to run through
the tubing and fall out into a basin that would remove the blood from the system in a
sanitary manner.
After the creation of the first physical model of the test block, several improvements were
made on the design of the resistance block. The initial design of the system included 16
resistance blocks to mate with 16 test blocks. It was found that there was no need for 16
individual resistance blocks, so a new single block was designed. This block utilized the
same sized tubes, but they were arranged in a 24 x 16 matrix, still spaced at 4.5mm
between the centers of the tubes. This design change would help create a better airtight
connection with the vacuum connection, as well as ease the process of assembling the
device, since aligning fewer parts makes the process quicker and safer.
Another observation made from the first physical model was the need for features that
help to align the male and female ends of the tubes. This feature was already discussed in
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the previous section. It involved the passing of guiding rods made of tungsten carbide
through stainless steel tubes cast through the long dimension of the resistance block. The
arrTangement of the stainless steel guiding tubes was such that it matched exactly with the
arrangement on the test blocks, and only allowed for the blocks to be mated in one
manner, so as to not confuse the direction in which the blocks sat.
3.4.3 Blood Loading Mechanism
The blood loading mechanism (BLM) was designed as a stand for the whole apparatus,
on which the test blocks would directly rest. This piece had 16 2mm deep wells arranged
in an 8 x 2 configuration. These wells were dimensioned to give clearance to the lmm
step at the end of each test block, and align the blocks in relation to each other in order to
match the tubes to the wells in the 384 well plate. At the bottom of each well in the BLM,
there was a hole that passed through the thickness of the piece that allowed for a nozzle
to connect the well to a blood supplying tube. A schematic including the dimensions of
the device is shown in Figure 8, and a three-dimensional drawing of the piece is found in
Figure 9.
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Figure 8: Schematic of the blood loading mechanism with dimensions included in mm. (A=3.l8mm)
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Figure 9: Three-dimensional drawing of the blood loading mechanism.
The nature of this piece required it to be in contact with a great deal of blood, and
therefore needed to be constructed of a material that was compatible with blood and did
not react in its presence. The piece was designed to be made of Silastic® silicone rubber
which is safe for use in medical devices and pharmaceutical applications, and is also
safely sterilized in an autoclave.
3.4.4 Vacuum Connection
The vacuum connection (VC) was designed as the piece that would sit on top of the
resistance block, which in turn sits on top of the test blocks. This connection would
provide the system with the pressure drop necessary to drive the blood from its reservoir
and through the test and resistance tubing. The VC has enough clearance to allow the
resistance block to slip into the piece, with a 3.35mm deep lip surrounding the block, to
ensure a tight vacuum seal. The piece also had enough clearance to allow the 2cm tube
protrusions from the resistance block to fit safely. There was also another hole on the
short side of the VC that allowed for blood that had flowed through the tubing and spilled
out through the protruding end to escape the system. A nozzle was be fitted to this hole
and another vacuum hose connected to the system to allow for the removal of the used
blood. A schematic of this piece with dimensions is presented in Figure 10 and a three-
dimensional drawing is presented in Figure 11.
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Figure 10: Schematic of the VC with dimensions included in mm. (A=6.35mm, B=3.00mm,
C=6.35mm)
Figure 11: Three-dimensional drawing of the VC.
As shown in Figure 11, the interior of the VC contained a set of tapped holes of 9.525mm
(3/8") depth of a diameter equal to that of the guiding rods that passed through the test
and resistance blocks. The VC will serve as a stable base off of which the guiding rods
can be aligned, which in turn aligns the resistance and test blocks. In addition, the VC
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could connect to the test blocks when they were organized in their 8 x 2 matrix, during
the platelet assaying phase of the testing. During this phase, Triton X was sucked up into
the test tubing, and held in place for about 30 minutes. A vacuum connection was
necessary to i]Introduce the Triton X into the test capillaries, and it was therefore
convenient to be able to utilize the same vacuum connection for both phases of the
testing. Finally, this piece will most likely be made of a material that is easy to machine
but also strong enough to allow for the guiding rods to align parallel to each other. In this
case, a material like aluminum may work best.
3.4.5 384 Well Plate Connection / Buffer Hopper
The buffer hopper (BH) was originally designed as a piece of this system that would fit
on top of the test blocks and serve as a container that would simply hold a supply of
buffer. This buffer was then sucked downward through the test tubing, into the blood
hopper, and out through the secondary vacuum holes found on the long side of the test
blocks. The design constraints of the BH were that it simply had to fit around and on top
of the 16 test block matrix, create a water-tight seal against the rubber of the blocks, and
be able to hold enough buffer solution to clear out the test tubes. The original design was
composed of a sort of framing piece that sat around and above the test pieces with the use
of a stepped lip, and had a tall wall that created an open top reservoir for the buffer with
the use of the surface of the top of the test block.
The 384 well plate connection (WPC) was a piece designed very similarly to the BLM.
The top of the WPC was designed and dimensioned exactly like the top of the BLM, with
rectangular wells arranged in an 8 x 2 matrix. The bottom of the WPC was where the
design differs from that of the BLM. The bottom had a section extruded from it that
allowed for it to mate with the top of a 384 well plate. A 384 well plate had a particular
rectangular shape with a cut off comer, which did not allow for confusion when mating
the part to the WPC. A photograph of a 384 well plate is shown in Figure 12, and its
dimensions are found in Figure 13.
Figure 12: A generic 384 well plate.
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Figure 13: Dimensioned schematic of a 384 well plate with dimensions included in mm and inches.
Since one side of the bottom mated directly onto the 384 well plate and the other side
mated to test blocks, the piece lined up the test tubes to their corresponding wells on the
plate. Another difference between the WPC and the BLM is that the wells in the WPB
passed through the thickness of the material to create rectangular holes clear through the
piece. The material left between the wells allowed the test pieces to align correctly
against each other with the use of their stepped ends.
The most current design for the 384 well plate connection combined its design with that
of the buffer hopper. The overall design of the WPC remained mostly the same. The only
difference was found in the greater thickness of the material, and the increased depth of
the extrusion in the material that allows for the 384 well plate to mate with the WPC. The
WPC can be utilized as a buffer hopper by turning it over and mating one side against the
open end of the test blocks during the buffer step of testing. The other side of the WPC,
which was capable of mating with a 384 well plate, could now double as a buffer hopper
that sat above the test blocks. A schematic and a three-dimensional drawing of this piece
are shown in Figures 14 and 15 respectively.
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Figure 14: Schematic of the 384 well plate connector / buffer hopper with dimensions included in
mm.
Figure 15: Figure _: Three-dimensional drawing of the 384 well plate connector / buffer hopper.
The top side, which mates to the bottoms of the test blocks to connect to the 384 well plate, is shown
on the left. The bottom side, which is the buffer hopper, is on the right.
Since the depth of the extrusion that mates with the 384 well plate was increased, a
spacer now has to be placed under the plate in order to raise it off of a table and butt it up
against the inside lip at the end of the extrusion. The piece will be fabricated from delrin
because compatibility with blood is not required in this piece, and the material is easy to
machine. The combination of two functions into one part made the whole setup of the
apparatus easier and it was simply one piece less to manufacture.
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CHAPTER 4
Linear Flow Model (Model B) Biological Validation
4.1 Purpose of Biological Validation
The final type of bench top testing that was performed was a biological validation. The efficacy
of the actual testing method needed to be examined before the components were created. These
tests were basically trying to answer the question about whether a significant biological signal
could be read from the 10cm long, 300 micron I.D tubes. These tests would also indicate other
problems that may arise once the components of the machine were created and assembled, such
as the formation of blood clots in the tubing, the effects of reversing the flow when passing
buffer through the tubes, and the effect of priming the apparatus before running it.
4.2 Test Method Employed During Biological Validation
The test method used was basically the core steps of the method outlined earlier for the use of the
final testing apparatus. Six capillary tubes were introduced into the ends of pipette tips, which
were, in turn, connected to rubber tubing that connected all the pipette tips in series. This rubber
tubing was then connected to the end of a syringe pump. This setup is shown in Figure 15.
Figure 16: (Left) Syringe pump setup connected to two capillary tubes. The pump is pushing ink and water
through the tubes, into the catching reservoir. (Right) Buffer suction setup. The Syringe pump is now set up
to suck buffer solution from a reservoir through the tubes and into a syringe.
The syringe pump was filled with about 3mL of blood, turned on, and left at a setting of 108
mJL/h. The blood from the syringe is expelled through the capillary tubing and out to a waste
container with bleach. After the 1-2 minutes of running the blood through the tubes, the tubes
were removed from the pipette tips and connected to a new rubber tubing/pipette tips setup. This
setup was then connected to another syringe in the syringe pump, but this time set up for suction
instead of expulsion. This tubing system was initially primed with Tyrodes buffer, and then the
open ends of the capillary tubes were placed into a bath of more buffer and the pump was set at
108 mL/h. The buffer ran in the opposite direction as the blood, to ensure that no more blood
passed through the tubing and changed the results of the initial blood run. The buffer solution ran
through the tubing for about 2 minutes, after which, the capillary tubes were removed from the
Chapter 4: Linear Flow Model (Model B) Biological Validation 39
rubber tubing/pipette tip setup, and installed at the end of new pipette tips on a multipipetter. At
this point, 7.5 [tL of prepared 1% Triton X solution were sucked into each of the six tubes, and
the fluid was suspended in the tubes for a period of 20 minutes. Finally, the solution in the tubes
was expelled into 6 wells of a 384 well plate. Another 7.5 pL of Cytotox 96 was placed into each
of the wells, and the plate was placed into a plate-reading spectrophotometer set at 490 nm
wavelength. Finally, the plate reader outputted its light readings in the form of a print out with
relative light intensity measurements on it.
4.3 Results and Conclusions
The biological validation testing results indicated that the capillary tube provided biological
signals on the same level as the rotating tube tests [35]. The more important observations derived
from these tests dealt with the fragility of the glass tubes, the difficulty in lining them up, and the
ease with which blood could clot inside the tubes. Because of the fragility of the tubes and the
amount of times that they needed to be removed from one set of rubber tubing and attached to
another set, a connector was made to hold all of the glass tubes together. This connector
decreased the amount of broken tubes and the amount of time needed to made and break all the
connections. The decreased amount of time between test phases also helped with the clotting of
blood, which was found to be a considerable problem at times. The longer blood stayed stagnant
in the pipette tips or in the capillary tubing, the higher the chance of a blood clot rose. The
emergence of a blood clot would block nearly, if not all the blood to one of the tubes, which
changes the flow rates through all the other tubes and provides no useful results from the blocked
tube. At times, a blood clot would also be difficult to detect during a test, so that a possibly
fixable problem would go unnoticed and unresolved. It was finally determined that this sort of
problem would be much less prevalent in the proposed apparatus because of the easy and swift
manner in which one can pass from one phase of a test to another. In addition, the apparatus will
have very little volume devoted to loading the blood into the tubes, where blood could either
become stagnant or completely clot a path.
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CHAPTER 5
Conclusions and Future Directions
In review, this document described the process taken in choosing the one-pass, linear
flow, high-throughput system as opposed to the rotational high-throughput system. The
testing system was chosen on a theoretical fluid mechanics basis. The multiple
components for this system were then designed individually, and the designs evolved for
usability of the machine as a whole. Solid models of the evolved components were
created as a 'rapid prototyping" mechanism, in order to determine potential problems
during the use of the machine. In order to test some of the important mechanical and
biological aspects of the apparatus, bench top tests had been formulated. A preliminary
model of the testing block was created and handled in order to find ergonomics and
safety problems that could not be determined from solid models on a computer screen.
Currently, biological bench top testing of the blood flow mechanism is being is being
conducted, to finalize the details concerning blood shear rates, flow of buffer through the
tubes, and assaying and reading of the biological signal.
The most immediate next steps in this project involve the design of mold pieces to
quickly and easily cast the test and resistance blocks. After that, the mold pieces and
other parts of the machine will be machined and assembled. After the flow system
machine has been created, a series of test may be applied to establish the machines
accuracy when, for example, different concentrations of chemicals are used to treat blood
samples or coat the tube surfaces. Also, tests would be formulated to determine the
precision of the system and the useful number of experimental repeats to ensure the
dependability of the results.
Pre-clinical studies should follow these accuracy and precision tests. These pre-clinical
studies include testing on: "normal" populations, animal studies, and validation studies.
Testing on a "normal" population means that the tests will utilize the blood of relatively
healthy persons. These tests would allow for the establishment of the range of biological
signals derived from healthy persons, which in turn, begins the calibration of this
instrument as a possible future clinical tool. The next step, animal studies, will allow for
the creation of perturbations in the animal's blood and cardiovascular system. These
perturbations by coagulants and anticoagulants will create controlled variations in
animals, resulting in specific biological signal readings to add to the calibration of the
device.
The final type of testing in the pre-clinical studies is the validation study, where a
population with a known disease would be chosen and tested upon. These results could
be compared to those from the animal testing and can add to the results used toward the
calibration of the device. The patients utilized in this study fall into two categories: low-
coagulant states and pro-coagulant states. Persons in low-coagulant states may exhibit,
for example, vWF disease, Thrombophilius A or B, Factor 8 or 9 deficiencies, Bernard
Soulier syndrome, or Gladzmann's thrombocytopenia. Persons in pro-coagulant states
may exhibit Factor 5 ligand - hypercoagulable state, high homosystein, lupus
anticoagulant, antithrombin 3 deficiency, or protein c or s deficiency.
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Following the pre-clinical studies, the last step is the clinical studies. By this phase,
several machines will have been produced and placed into clinical settings. In the case of
clinical thrombosis, patients are usually given antithrombotics or anticoagulants. At this
point, the goal would be to have this machine used as a tool to determine if and how
much anticoagulant should be used on a particular patient. In conclusion, the ideal case to
test out the capabilities of this system would include application on a patient or
population where the decision to use antithrombotics or anticoagulants in the treatment of
thrombosis is not obvious or easy to make. This sort of future testing would test out the
last set of capabilities and performance parameters, which could potentially open the door
to widespread use of this new useful and efficient clinical and research tool.
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